Leukocyte lysosomal enzymes in Alzheimer's disease and Down's syndrome

Svjetlana Kalanj-Bognar, Tatjana Rundek, Ivana Furač, Vida Demarin, Čedomir Ćosović

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Previous studies suggested the possibility of accelerated lysosomal degradation of brain gangliosides in Alzheimer's disease (AD). As AD pathology affects both neural and nonneural tissues, the aim of this study was to determine possible changes of glycosphingolipid metabolism in available peripheral cells in AD and Down's syndrome (DS). The activities of several lysosomal enzymes involved in catabolism of gangliosides and sulfatides were measured in leukocytes from subjects with dementia of the Alzheimer type, DS, and age-matched controls, by fluorimetry and spectrophotometry using specific substrates. The results showed a statistically significant increase of β-galactosidase activity in both dementia of the Alzheimer type and DS leukocytes when compared with age-matched controls (p < .01 and p < .05, respectively; Student's t test). Not significantly increased activities of β-galactosidase, β-hexosaminidase, β-hexosaminidase A, and slightly decreased activity of arylsulfatase A were observed in control leukocytes with aging. Our results indicate that a metabolic dysfunction and the acceleration of at least some lysosomal catabolic pathways are present in AD and DS nonneural cells.

Original languageEnglish
JournalJournals of Gerontology - Series A Biological Sciences and Medical Sciences
Volume57
Issue number1
StatePublished - Jan 29 2002
Externally publishedYes

Fingerprint

Down Syndrome
Alzheimer Disease
Leukocytes
Enzymes
Galactosidases
Gangliosides
Dementia
Hexosaminidase A
Cerebroside-Sulfatase
Sulfoglycosphingolipids
Hexosaminidases
Fluorometry
Glycosphingolipids
Spectrophotometry
Pathology
Students
Brain

ASJC Scopus subject areas

  • Aging

Cite this

Leukocyte lysosomal enzymes in Alzheimer's disease and Down's syndrome. / Kalanj-Bognar, Svjetlana; Rundek, Tatjana; Furač, Ivana; Demarin, Vida; Ćosović, Čedomir.

In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 57, No. 1, 29.01.2002.

Research output: Contribution to journalArticle

Kalanj-Bognar, Svjetlana ; Rundek, Tatjana ; Furač, Ivana ; Demarin, Vida ; Ćosović, Čedomir. / Leukocyte lysosomal enzymes in Alzheimer's disease and Down's syndrome. In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 2002 ; Vol. 57, No. 1.
@article{372728414f6e4d6283f32a1b78f32c4f,
title = "Leukocyte lysosomal enzymes in Alzheimer's disease and Down's syndrome",
abstract = "Previous studies suggested the possibility of accelerated lysosomal degradation of brain gangliosides in Alzheimer's disease (AD). As AD pathology affects both neural and nonneural tissues, the aim of this study was to determine possible changes of glycosphingolipid metabolism in available peripheral cells in AD and Down's syndrome (DS). The activities of several lysosomal enzymes involved in catabolism of gangliosides and sulfatides were measured in leukocytes from subjects with dementia of the Alzheimer type, DS, and age-matched controls, by fluorimetry and spectrophotometry using specific substrates. The results showed a statistically significant increase of β-galactosidase activity in both dementia of the Alzheimer type and DS leukocytes when compared with age-matched controls (p < .01 and p < .05, respectively; Student's t test). Not significantly increased activities of β-galactosidase, β-hexosaminidase, β-hexosaminidase A, and slightly decreased activity of arylsulfatase A were observed in control leukocytes with aging. Our results indicate that a metabolic dysfunction and the acceleration of at least some lysosomal catabolic pathways are present in AD and DS nonneural cells.",
author = "Svjetlana Kalanj-Bognar and Tatjana Rundek and Ivana Furač and Vida Demarin and Čedomir Ćosović",
year = "2002",
month = "1",
day = "29",
language = "English",
volume = "57",
journal = "Journals of Gerontology - Series A Biological Sciences and Medical Sciences",
issn = "1079-5006",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Leukocyte lysosomal enzymes in Alzheimer's disease and Down's syndrome

AU - Kalanj-Bognar, Svjetlana

AU - Rundek, Tatjana

AU - Furač, Ivana

AU - Demarin, Vida

AU - Ćosović, Čedomir

PY - 2002/1/29

Y1 - 2002/1/29

N2 - Previous studies suggested the possibility of accelerated lysosomal degradation of brain gangliosides in Alzheimer's disease (AD). As AD pathology affects both neural and nonneural tissues, the aim of this study was to determine possible changes of glycosphingolipid metabolism in available peripheral cells in AD and Down's syndrome (DS). The activities of several lysosomal enzymes involved in catabolism of gangliosides and sulfatides were measured in leukocytes from subjects with dementia of the Alzheimer type, DS, and age-matched controls, by fluorimetry and spectrophotometry using specific substrates. The results showed a statistically significant increase of β-galactosidase activity in both dementia of the Alzheimer type and DS leukocytes when compared with age-matched controls (p < .01 and p < .05, respectively; Student's t test). Not significantly increased activities of β-galactosidase, β-hexosaminidase, β-hexosaminidase A, and slightly decreased activity of arylsulfatase A were observed in control leukocytes with aging. Our results indicate that a metabolic dysfunction and the acceleration of at least some lysosomal catabolic pathways are present in AD and DS nonneural cells.

AB - Previous studies suggested the possibility of accelerated lysosomal degradation of brain gangliosides in Alzheimer's disease (AD). As AD pathology affects both neural and nonneural tissues, the aim of this study was to determine possible changes of glycosphingolipid metabolism in available peripheral cells in AD and Down's syndrome (DS). The activities of several lysosomal enzymes involved in catabolism of gangliosides and sulfatides were measured in leukocytes from subjects with dementia of the Alzheimer type, DS, and age-matched controls, by fluorimetry and spectrophotometry using specific substrates. The results showed a statistically significant increase of β-galactosidase activity in both dementia of the Alzheimer type and DS leukocytes when compared with age-matched controls (p < .01 and p < .05, respectively; Student's t test). Not significantly increased activities of β-galactosidase, β-hexosaminidase, β-hexosaminidase A, and slightly decreased activity of arylsulfatase A were observed in control leukocytes with aging. Our results indicate that a metabolic dysfunction and the acceleration of at least some lysosomal catabolic pathways are present in AD and DS nonneural cells.

UR - http://www.scopus.com/inward/record.url?scp=0036141737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036141737&partnerID=8YFLogxK

M3 - Article

C2 - 11773202

AN - SCOPUS:0036141737

VL - 57

JO - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

JF - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

SN - 1079-5006

IS - 1

ER -